New Delhi: At a media workshop on the clinical research industry (CRO) held at Delhi on July 13, 2012, industry experts ...
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...
Singapore: Sundia MediTech, a China-based CRO company, appointed Mr Albert Liou, Mr Haibo Wang, and Ms Wilma Wei as inde...
‎Singapore: ReSearch Pharmaceutical Services, a clinical research firm, has appointed Mr Marc Wolff as its chief f...
Singapore: WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with ...
Singapore: Vietnam Ministry of Health's Administration of Science, Technology and Training (ASTT) has signed an agreemen...
Singapore: Mayne Pharma has entered into a binding agreement to acquire Metrics, a privately-owned, US-based provider of...
Pharmaceutical and biotechnology companies reap the most benefit from their strategic collaborations, by working with su...
Singapore: UK-based contract organization TranScrip Partners launched its operations in Australia. TranScrip Partners su...
Singapore: Pharmaceutical Product Development, a leading global contract research organization, has appointed Dr Louis R...
Singapore: Parexel, a global biopharmaceutical services provider, has launched a new service line designed to provide a ...
Singapore: Dx assays, Singapore-based provider of contract development services to the global diagnostics, pharmaceutic...
Singapore: New Delhi-based Curadev Pharma has successfully advanced its oncology program to the next stage with its clin...
Singapore: Harlan Contract Research Services (CRS), a division of Harlan Laboratories, a privately held provider of gene...
Singapore: Shanghai SynTheAll (STA) Pharmaceutical, subsidiary of WuXi PharmaTech, a leading pharmaceutical, biotechnolo...
Singapore: Pharmaron, a premier R&D service provider for the pharmaceutical and biotech industries, has formed a dru...
Singapore: SFJ Pharmaceuticals, primarily focused on funding and executing phase III studies of drugs, has entered into ...
The bioservices sector witnessed a growth of 15.5 percent in 2011-12 in spite of facing many issues from the regulatory ...
